Ascentage Pharma Group International (AAPG)

NASDAQ: AAPG · Real-Time Price · USD

13.64

+0.08 (0.59%)

Nov 3, 2026, 11:08 AM EST - Market open

AAPG Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	642.64	574.12	980.65	221.98	209.71	27.91
Revenue Growth	11.93%	-41.45%	341.77%	5.85%	651.38%	124.18%
Gross Profit	603.62	525.18	951.57	191.44	187.71	24.58
Operating Income	-1,410	-1,212	-378.8	-891.99	-883.41	-933.17
Net Income	-1,469	-1,243	-405.43	-925.64	-882.92	-782.42
Earnings Per Share	-3.95	-3.49	-1.34	-3.28	-3.35	-3.07
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Chinese Mainland	642.64	574.12	302.24	221.98	209.71	14.97
Switzerland	-	-	678.42	-	-	-
Total	642.64	574.12	980.65	221.98	209.71	27.91

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,896	2,472	1,267	1,100	1,504	1,748
Total Debt	2,095	1,980	1,668	1,796	1,793	1,084
Net Cash (Debt)	-198.99	492.53	-401.92	-695.21	-288.58	663.68
Net Cash Growth	-	-	-	-	-	33.34%
Net Cash Per Share	-0.53	1.38	-1.33	-2.46	-1.09	2.61

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-1,323	-1,174	-111.36	-726.08	-653.92	-604.68
Capital Expenditures	-19.39	-27.57	-24.29	-46.11	-203.29	-435.42
Free Cash Flow	-1,343	-1,202	-135.65	-772.19	-857.2	-1,040
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	93.93%	91.48%	97.03%	86.24%	89.51%	88.08%
Operating Margin	-219.48%	-211.14%	-38.63%	-401.83%	-421.25%	-3343.50%
Pretax Margin	-226.27%	-215.29%	-40.31%	-420.24%	-423.05%	-2981.90%
Profit Margin	-228.54%	-216.47%	-41.34%	-416.98%	-421.02%	-2803.38%
FCF Margin	-208.93%	-209.31%	-13.83%	-347.86%	-408.75%	-3726.60%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	13.10	30.10	13.48	31.78	27.99	212.05